XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
At The Market Offering
Common Stock
At The Market Offering
Additional Paid-in Capital
At The Market Offering
Equity Line Financing
Common Stock
Equity Line Financing
Additional Paid-in Capital
Equity Line Financing
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balances at Dec. 31, 2021             $ 22 $ 145,453 $ (94,004) $ (198) $ 51,273
Beginning Balances (in shares) at Dec. 31, 2021             22,230,032        
Shareholders' Equity                      
Exercise of common stock options               303     303
Exercise of common stock options (in shares)             348,552        
Equity-based compensation               1,001     1,001
Other comprehensive gain                   1 1
Net loss                 (3,838)   (3,838)
Ending Balances at Mar. 31, 2022             $ 22 146,757 (97,842) (197) 48,740
Ending Balances (in shares) at Mar. 31, 2022             22,578,584        
Beginning Balances at Dec. 31, 2021             $ 22 145,453 (94,004) (198) $ 51,273
Beginning Balances (in shares) at Dec. 31, 2021             22,230,032        
Shareholders' Equity                      
Exercise of common stock options (in shares)                     367,875
Net loss                     $ (9,590)
Ending Balances at Jun. 30, 2022             $ 22 147,671 (103,594) (200) 43,899
Ending Balances (in shares) at Jun. 30, 2022             22,597,907        
Beginning Balances at Mar. 31, 2022             $ 22 146,757 (97,842) (197) 48,740
Beginning Balances (in shares) at Mar. 31, 2022             22,578,584        
Shareholders' Equity                      
Exercise of common stock options               22     $ 22
Exercise of common stock options (in shares)             19,323       19,321
Equity-based compensation               892     $ 892
Other comprehensive gain                   (3) (3)
Net loss                 (5,752)   (5,752)
Ending Balances at Jun. 30, 2022             $ 22 147,671 (103,594) (200) 43,899
Ending Balances (in shares) at Jun. 30, 2022             22,597,907        
Beginning Balances at Dec. 31, 2022             $ 29 155,820 (115,401) (199) 40,249
Beginning Balances (in shares) at Dec. 31, 2022             28,991,548        
Shareholders' Equity                      
Equity-based compensation               1,187     1,187
Value of shares issued   $ 197 $ 197   $ 318 $ 318          
Shares issued 95,823     189,856              
Other comprehensive gain                   4 4
Net loss                 (6,172)   (6,172)
Ending Balances at Mar. 31, 2023             $ 29 157,522 (121,573) (195) 35,783
Ending Balances (in shares) at Mar. 31, 2023             29,277,227        
Beginning Balances at Dec. 31, 2022             $ 29 155,820 (115,401) (199) $ 40,249
Beginning Balances (in shares) at Dec. 31, 2022             28,991,548        
Shareholders' Equity                      
Exercise of common stock options (in shares)                     0
Net loss                     $ (10,898)
Ending Balances at Jun. 30, 2023             $ 30 160,851 (126,299) (196) 34,386
Ending Balances (in shares) at Jun. 30, 2023             30,286,582        
Beginning Balances at Mar. 31, 2023             $ 29 157,522 (121,573) (195) $ 35,783
Beginning Balances (in shares) at Mar. 31, 2023             29,277,227        
Shareholders' Equity                      
Exercise of common stock options (in shares)                     0
Equity-based compensation               1,025     $ 1,025
Value of shares issued             $ 1 2,304     2,305
Shares issued             1,009,355        
Other comprehensive gain                   (1) (1)
Net loss                 (4,726)   (4,726)
Ending Balances at Jun. 30, 2023             $ 30 $ 160,851 $ (126,299) $ (196) $ 34,386
Ending Balances (in shares) at Jun. 30, 2023             30,286,582